Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epidermal Langerhans cell development and differentiation

H Strobl1, E Riedl, C Bello-Fernandez

  • 1Institute of Immunology, University of Vienna, Austria.

Immunobiology
|April 30, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO).

Dermatology and therapy·2024
Same author

Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO).

Dermatology and therapy·2023
Same author

Speed of clinical improvement in the real-world setting from patient-reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeks.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

An integrated analysis of herpes virus infections from eight randomized clinical studies of baricitinib in adults with moderate-to-severe atopic dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Evaluation of community readiness for change prior to a participatory physical activity intervention in Germany.

Health promotion international·2021
Same author

Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab.

The Journal of dermatological treatment·2021
Same journal

WD-3 improves anti-PD-L1 therapy by remodeling the tumor immune microenvironment through gut microbiota.

Immunobiology·2026
Same journal

Interleukin 27 (IL-27) in gastrointestinal cancers: from dual roles in tumor immunity to immunotherapeutic opportunities.

Immunobiology·2026
Same journal

ST2-mediated ERK/JNK/P38/NF-κB signaling: a target of Biminkang mixture in minimal persistent inflammation of allergic rhinitis.

Immunobiology·2026
Same journal

Chronic stress promotes colorectal cancer progression by inducing M2 macrophage polarization and activating the CCL2-CCR2 axis.

Immunobiology·2026
Same journal

Spatial-cellular resolution analysis of ferroptosis-associated immune microenvironment heterogeneity in osteoarthritic cartilage.

Immunobiology·2026
Same journal

Exploring therapeutic targets for neuroinflammation in sepsis-associated encephalopathy: a combined network pharmacology and bioinformatics approach.

Immunobiology·2026
See all related articles

Epidermal Langerhans cells (LC) development is clarified using new in vitro methods. Transforming growth factor-beta 1 and FLT3 ligand are crucial for generating these immune cells from progenitor cells.

Area of Science:

  • Immunology
  • Developmental Biology
  • Hematopoiesis

Background:

  • Epidermal Langerhans cells (LC) are critical for host defense but their development and specialization remain poorly understood.
  • Key debates surround the signals required for LC differentiation, intermediate developmental stages, and their relationship to other hematopoietic lineages.

Purpose of the Study:

  • To investigate the in vitro development of Langerhans cells (LC) from hematopoietic progenitor cells.
  • To identify key signaling molecules essential for LC differentiation and colony formation.

Main Methods:

  • Utilized recently developed technologies for in vitro generation of dendritic cells (DC) with LC features from purified CD34+ progenitor cells.
  • Employed defined serum-free culture conditions with specific growth factors and cytokines.

Related Experiment Videos

Main Results:

  • Transforming growth factor-beta 1 (TGF-β1) was identified as an absolute requirement for in vitro LC development under serum-free conditions.
  • FLT3 ligand significantly enhanced in vitro LC development and enabled efficient colony generation from CD34+ progenitor cells.

Conclusions:

  • Established serum-free culture conditions for generating LC with typical features from progenitor cells.
  • Demonstrated the critical roles of TGF-β1 and FLT3 ligand in promoting LC development and hematopoiesis.